broussonetia kazinoki callus extract
extract of a culture of the callus of broussonetia kazinoki, moraceae
Identification
| Name | broussonetia kazinoki callus extract |
Regulatory
Physical Properties
| Food Chemicals Codex Listed | No |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | skin conditioning |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | cosmetic ingredient for skin conditioning |
| Recommendation for broussonetia kazinoki callus extract usage levels up to | not for fragrance use. |
| Recommendation for broussonetia kazinoki callus extract flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
broussonetia kazinoki var. ruyangensis callus extract
broussonetia monoica callus extract
extract of a culture of the callus of broussonetia kazinoki, moraceae
PubMed:
Correction: De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera).
PubMed:
Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6Kâdependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation.
PubMed:
Characterization of bionanocomposite films prepared with agar and paper-mulberry pulp nanocellulose.
PubMed:
De Novo assembly of expressed transcripts and global transcriptomic analysis from seedlings of the paper mulberry (Broussonetia kazinoki x Broussonetia papyifera).
PubMed:
A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced β-cell death through suppression of nuclear factor-κB activity.
PubMed:
Kazinol Q from Broussonetia kazinoki enhances cell death induced by Cu(II) through increased reactive oxygen species.
PubMed:
Inhibitory effects of heartwood extracts of Broussonetia kazinoki Sieb on the development of atopic dermatitis in NC/Nga mice.
PubMed:
New estrogenic compounds isolated from Broussonetia kazinoki.
PubMed:
Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki.
PubMed:
Antihyperglycemic effect of stem bark powder from paper mulberry (Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans Tokushima fatty rats.
PubMed:
Inhibitory effects of plant extracts on tyrosinase, L-DOPA oxidation, and melanin synthesis.
PubMed:
Inhibition of nitric oxide production on LPS-activated macrophages by kazinol B from Broussonetia kazinoki.
PubMed:
Studies on the constituents of Broussonetia species X. Six new alkaloids from Broussonetia kazinoki Sieb.
PubMed:
Five new diprenylated flavonols from the leaves of Broussonetia kazinoki.
PubMed:
The biosynthesis of broussonetines: origin of the carbon skeleton.
PubMed:
Studies on the constituents of Broussonetia species VIII. Four new pyrrolidine alkaloids, broussonetines R, S, T, and V and a new pyrroline alkaloid, broussonetine U, from Broussonetia kazinoki Sieb.
PubMed:
Studies on the constituents of Broussonetia species. VII. Four new pyrrolidine alkaloids, broussonetines M, O, P, and Q, as inhibitors of glycosidase, from Broussonetia kazinoki SIEB.
PubMed:
Cytotoxic isoprenylated flavans of Broussonetia kazinoki.
PubMed:
Studies on the constituents of Broussonetia species. III. Two new pyrrolidine alkaloids, broussonetines G and H, as inhibitors of glycosidase, from Broussonetia kazinoki Sieb.
PubMed:
Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki Sieb.